1. Home
  2. VRNA vs CMBT Comparison

VRNA vs CMBT Comparison

Compare VRNA & CMBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • CMBT
  • Stock Information
  • Founded
  • VRNA 2005
  • CMBT 1989
  • Country
  • VRNA United Kingdom
  • CMBT Belgium
  • Employees
  • VRNA N/A
  • CMBT N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • CMBT
  • Sector
  • VRNA Health Care
  • CMBT
  • Exchange
  • VRNA Nasdaq
  • CMBT NYSE
  • Market Cap
  • VRNA 2.2B
  • CMBT 2.5B
  • IPO Year
  • VRNA 2017
  • CMBT N/A
  • Fundamental
  • Price
  • VRNA $35.66
  • CMBT $12.70
  • Analyst Decision
  • VRNA Strong Buy
  • CMBT
  • Analyst Count
  • VRNA 6
  • CMBT 0
  • Target Price
  • VRNA $43.83
  • CMBT N/A
  • AVG Volume (30 Days)
  • VRNA 1.1M
  • CMBT 100.1K
  • Earning Date
  • VRNA 11-04-2024
  • CMBT 11-07-2024
  • Dividend Yield
  • VRNA N/A
  • CMBT 25.45%
  • EPS Growth
  • VRNA N/A
  • CMBT 75.60
  • EPS
  • VRNA N/A
  • CMBT 5.97
  • Revenue
  • VRNA $5,624,000.00
  • CMBT $982,850,000.00
  • Revenue This Year
  • VRNA N/A
  • CMBT N/A
  • Revenue Next Year
  • VRNA $554.09
  • CMBT $18.94
  • P/E Ratio
  • VRNA N/A
  • CMBT $2.06
  • Revenue Growth
  • VRNA 1127.95
  • CMBT N/A
  • 52 Week Low
  • VRNA $11.39
  • CMBT $12.64
  • 52 Week High
  • VRNA $40.13
  • CMBT $21.26
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 51.76
  • CMBT 24.71
  • Support Level
  • VRNA $36.49
  • CMBT $12.64
  • Resistance Level
  • VRNA $40.13
  • CMBT $13.20
  • Average True Range (ATR)
  • VRNA 2.01
  • CMBT 0.35
  • MACD
  • VRNA -0.30
  • CMBT -0.05
  • Stochastic Oscillator
  • VRNA 47.60
  • CMBT 7.08

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About CMBT EURONAV

CMB.Tech NV owns and operates a fleet of vessels for international maritime shipping and storage of crude oil and petroleum products. It generate a large parts of their revenue from voyage charters, including vessels in pools that predominantly perform voyage charters. The company organises itself into two segments: tankers and floating storage and offloading activities, or FSO. The tankers segment, which generates the majority of revenue, operates crude oil tankers on international markets. The FSO segment conducts floating production, floating storage, and offloading operations for crude oil and petroleum products.

Share on Social Networks: